基因检测市场规模、份额及成长分析（依技术、应用、产品、通路、最终用途及地区）－2025-2032 年产业预测

2023 年全球基因检测市场规模价值 80 亿美元，预计将从 2024 年的 98.4 亿美元成长到 2032 年的 515.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 23.0%。

由于技术进步、医疗保健需求增加以及公众意识增强，基因检测市场正在经历显着增长。这种快速成长主要归功于针对各种健康状况的提高意识和教育活动，以及广泛的媒体报导。技术创新，尤其是次世代定序（NGS），大大提高了基因检测的速度、准确性和可负担性。然而，它面临着道德和隐私挑战，包括基因资讯的滥用以及保险和就业领域的潜在歧视。儘管存在这些障碍，但基因检测的不断应用和基因组学的持续进步为市场提供了巨大的成长机会，预示着个人化医疗和医疗保健解决方案的光明未来。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

基因检测市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 次世代定序
• 阵列技术
• PCR检测
• FISH 侦测
• 其他的

基因检测市场规模（按应用和复合年增长率） (2025-2032)

• 市场概览
• 血统和种族
• 房产筛检
• 遗传疾病携带者状况
• 新生儿筛检
• 健康与保健 - 诱发因素/风险/倾向

基因检测市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 耗材
• 装置
• 软体和服务

基因检测市场规模（按渠道和复合年增长率） (2025-2032)

• 市场概览
• 在线的
• 离线

基因检测市场规模（按最终用途和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊所
• 诊断实验室
• 其他的

基因检测市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Illumina, Inc.（USA）
• Roche Holding AG（Switzerland）
• Thermo Fisher Scientific Inc.（USA）
• QIAGEN NV（Netherlands）
• Abbott Laboratories（USA）
• Agilent Technologies, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Danaher Corporation（USA）
• Myriad Genetics, Inc.（USA）
• 23andMe, Inc.（USA）
• Invitae Corporation（USA）
• Natera, Inc.（USA）
• NeoGenomics, Inc.（USA）
• Guardant Health, Inc.（USA）
• Siemens Healthineers AG（Germany）
• Hologic, Inc.（USA）
• BGI Genomics Co., Ltd.（China）
• Eurofins Scientific（Luxembourg）
• Adaptive Biotechnologies Corporation（USA）

结论和建议

Global Genetic Testing Market size was valued at USD 8.0 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 51.55 billion by 2032, growing at a CAGR of 23.0% during the forecast period (2025-2032).

The genetic testing market has experienced significant growth due to advancements in technology, increasing healthcare demands, and heightened public awareness. This surge is primarily driven by enhanced awareness and educational initiatives about various prevalent health conditions, supported by extensive media coverage. Technological innovations, particularly in Next-Generation Sequencing (NGS), have drastically improved the speed, accuracy, and affordability of genetic tests. However, the market faces challenges regarding ethical concerns and privacy issues, including the potential misuse of genetic information and discrimination from insurance or employment sectors. Despite these hurdles, the expanding applications of genetic testing and ongoing advancements in genomics present substantial growth opportunities for the market, signaling a promising future in personalized medicine and healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genetic Testing Market Segments Analysis

Global Genetic Testing Market is segmented by Technology, Application, Product, Channel, End Use and region. Based on Technology, the market is segmented into Next Generation Sequencing, Array Technology, PCR - based Testing, FISH and Others. Based on Application, the market is segmented into Ancestry & Ethnicity, Traits Screening, Genetic Disease Carrier Status, New Baby Screening and Health and Wellness - Predisposition/ Risk / Tendency. Based on Product, the market is segmented into Consumables, Equipment and Software & Services. Based on Channel, the market is segmented into Online and Offline. Based on End Use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Genetic Testing Market

The global genetic testing market is significantly propelled by the increasing awareness and demand for personalized medicine. As individuals become more informed about the benefits of tailored healthcare solutions, there is a substantial shift towards genetic testing, which provides valuable insights into a person's unique genetic makeup. This heightened awareness fosters a growing preference for personalized treatment plans that can enhance efficacy and minimize adverse effects. Additionally, advancements in technology and the consequential reduction in testing costs have further fueled consumer interest. Consequently, the focus on personalized approaches in medicine continuously drives the expansion of the genetic testing sector worldwide.

Restraints in the Global Genetic Testing Market

One of the significant challenges facing the global genetic testing market is the issue of limited insurance coverage. Many insurance providers are hesitant to fully cover genetic testing expenses, often due to high costs and perceived uncertainties regarding the benefits of various tests. This lack of comprehensive coverage can deter individuals from seeking necessary genetic assessments, as out-of-pocket expenses may be prohibitive for many patients. Consequently, this restriction hampers market growth by limiting access to testing services, which in turn affects patient outcomes and the overall demand for advancements in genetic testing technologies and services.

Market Trends of the Global Genetic Testing Market

The Global Genetic Testing market is witnessing a significant trend of expanding beyond traditional DNA analysis to incorporate advanced methodologies, including RNA profiling and epigenetic testing. This evolution is pivotal as it enhances the detection of genetic variations and provides profound insights into how these alterations influence gene expression and overall health. By considering factors that do not alter the DNA sequence yet affect cellular functionality, genetic testing is becoming more comprehensive and personalized. This trend is expected to drive demand for innovative testing solutions, ultimately leading to more precise healthcare interventions and tailored treatments, thereby propelling market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Genetic Testing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Next Generation Sequencing
• Array Technology
• PCR - based Testing
• FISH
• Others

Global Genetic Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Ancestry & Ethnicity
• Traits Screening
• Genetic Disease Carrier Status
• New Baby Screening
• Health and Wellness - Predisposition/ Risk / Tendency

Global Genetic Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Equipment
• Software & Services

Global Genetic Testing Market Size by Channel & CAGR (2025-2032)

• Market Overview
• Online
• Offline

Global Genetic Testing Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Others

Global Genetic Testing Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Channel, End Use)
  • US
  • Canada
• Europe (Technology, Application, Product, Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 23andMe, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adaptive Biotechnologies Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations